BioCreate Program
At a glance
- Max. $150,000
- Open Date : May 15, 2023
- Closing date : November 30, 2023
- All industries
- Ontario Genomics
Overview
Eligibility criteria
Who is eligible
Eligible companies for this grant are those with a focus on bioproducts & environment, human health, agriculture & food.
- Virica Biotech
- Spectra Plasmonics
- QurCan Therapeutics
- Escarpment Labs
- Performance Plants Inc.
- Liven Proteins
- Kraken Sense
- Index Biosystems
Eligible expenses
There are eligible expenses for this grant. The eligible expenses include:
- Laboratory supplies and equipment
- Research personnel salaries
- Data analysis software
- Travel for research purposes
- Publication costs
Eligible projects & activities
There are projects and activities eligible for this grant:
- Virica Biotech participated in the BioCreate Program under Cohort 2 for Bioproducts & EnvironmentHuman Health.
- Spectra Plasmonics was part of the BioCreate Program in Cohort 2 focusing on Agriculture & Food.
- QurCan Therapeutics joined the BioCreate Program within Cohort 2 targeting Human Health.
- Escarpment Labs competed in the BioCreate Program under Cohort 2 for Genome Centre: Ontario Genomics.
Evaluation & selection criteria
There are evaluation and selection criteria for this grant. The evaluation and selection criteria for this grant are as follows:
- Scientific/Technical Merit
- Feasibility and Work Plan
- Potential Impact
- Track Record and Capability of the Applicant
How to apply
Grant Summary
Virica Biotech, Spectra Plasmonics, QurCan Therapeutics, and Escarpment Labs were past participants in the BioCreate Program organized by Ontario Genomics. Performance Plants Inc., Liven Proteins, Kraken Sense, and Index Biosystems have also previously taken part in this program.
Understanding the BioCreate Program by Ontario Genomics
The BioCreate Program by Ontario Genomics is a competitive initiative aimed at fostering innovation in various sectors, including Bioproducts & Environment, Human Health, Agriculture & Food, and related fields. Companies like Virica Biotech, Spectra Plasmonics, QurCan Therapeutics, and Escarpment Labs have all been part of this program in the past, benefiting from resources, expertise, and support provided by Ontario Genomics.
Performance Plants Inc., Liven Proteins, Kraken Sense, and Index Biosystems have also participated in previous cohorts, showcasing the program's impact on a diverse range of projects and ventures. Through the BioCreate Program, participating companies have had the opportunity to advance their research, develop innovative solutions, and contribute to the growing biotech landscape in Ontario and beyond.
With a focus on driving collaboration, innovation, and commercialization in the biotechnology sector, the BioCreate Program continues to support emerging companies and entrepreneurs in realizing their potential and making a positive impact on various industries. The success stories of past participants highlight the program's role in nurturing talent, encouraging groundbreaking research, and accelerating the development of bio-based products with real-world applications.
As a key player in fostering a thriving biotech ecosystem, Ontario Genomics plays a crucial role in connecting industry partners, researchers, and investors to drive progress and create sustainable solutions for pressing challenges. By supporting initiatives like the BioCreate Program, Ontario Genomics is actively contributing to the growth and success of the biotech sector in Ontario, ultimately benefiting society, the economy, and the environment.
